Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christelle Dousset
ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells With a BCL-2high/McL-1low Profile and Synergizes With Other Antineoplastic Agents
Clinical Cancer Research
Cancer Research
Oncology
Complex Interplay of Activating and Inhibitory Signals Received by v 9V 2 T Cells Revealed by Target Cell 2-Microglobulin Knockdown
Journal of Immunology
Allergy
Immunology
Related publications
Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells
Cancer Cell International
Cancer Research
Oncology
Genetics
Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A
Apoptosis : an international journal on programmed cell death
Cell Biology
Pharmacology
Biochemistry
Clinical Biochemistry
Cancer Research
Pharmaceutical Science
Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Loss in McL-1 Function Sensitizes Non-Hodgkin’s Lymphoma Cell Lines to the BCL-2-selective Inhibitor Venetoclax (ABT-199)
Blood Cancer Journal
Oncology
Hematology
Interleukin-21 Effectively Induces Apoptosis in Mantle Cell Lymphoma Through a STAT1-dependent Mechanism
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Crystal Structure of ABT-737 Complexed With BCL-xL: Implications for Selectivity of Antagonists of the BCL-2 Family
Cell Death and Differentiation
Cell Biology
Molecular Biology
Long-Term Outcomes and Mutation Profiling of Patients With Mantle Cell Lymphoma (MCL) Who Discontinued Ibrutinib
British Journal of Haematology
Hematology
